Additionally, dual ETA/B receptor antagonism or selective ETA receptor blockade has shown to prevent VEGF-inhibitor-induced hypertension, indicating that stimulation of ETA receptors by ET-1 is responsible for this condition (Carneiro et al., 2008). This evidence concerns the gene VEGFA and hypertensive disorder.